FILLER LINE.Class III intradermal injectable medical devices CE 0373 Formula with European Patent No. 21202527.4 Skin-F ® 22 In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and proline. Skin-F ® 24 In 1-mL syringe, contains 24 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline. Skin-F ® 26 In 1-mL syringe, contains 26 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline. Skin-F ® MAN 22 In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and proline. Skin-F ® MAN 24 In 1-mL syringe, contains 24 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline. Skin-F ® MAN 26 In 1-mL syringe, contains 26 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline. Fillervit ® F 22 In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and proline. Fillervit ® F 24 In 1-mL syringe, contains 24 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline. Fillervit ® F 26 In 1-mL syringe, contains 26 mg/ml cross-linked sodium hyaluronate, in sterile buffered water, with added glycine and proline.